EUVIMEDEUVIMED entdecken
Crossref

Development and Validation of a Stability-Indicating Analytical Method for Dapagliflozin in Bulk and Pharmaceutical Dosage Form

Jyoti B. Salgar, Dr. Sanjay Bais, Sunil S. Barkade, Sukanya R. Mane, Rohit S. Doshi, Manjusha M. Patil, Sima T Kamble, Nida N Mulla

International Journal of Drug Delivery Technology · 05.05.2026 · 16 (24s)

DOI: 10.25258/ijddt.16.24s.58 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.05.2026. Verfasst von Jyoti B. Salgar und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dapagliflozin is an efficient and reliable drug. The RP-HPLC technique was created and approved for the quantitative measurement of dapagliflozin in pharmaceutical dosage forms and bulk. Chromatographic separation was accomplished with an appropriate C18 column and an optimized mobile phase composition to guarantee sufficient retention and symmetrical, sharp peaks. Over the chosen concentration range, the approach showed satisfactory linearity with correlation coefficients exceeding accepted validation limits. ICH Q2(R1) recommendations were followed in the assessment of accuracy, precision, specificity, robustness, system applicability, limit of detection, and limit of quantification. The method showed excellent sensitivity and reproducibility, with minimal interference from excipients or potential degradation products. Stress studies confirmed that the procedure is stability-indicating and capable of distinguishing dapagliflozin from its degradation products. All things considered, the established RP-HPLC method is straightforward, quick, and appropriate for regular stability testing and quality monitoring of formulations containing dapagliflozin.

Zitieren

APA

Salgar, J. B., Bais, D. S., Barkade, S. S., Mane, S. R., Doshi, R. S., Patil, M. M., Kamble, S. T., & Mulla, N. N. (2026). Development and Validation of a Stability-Indicating Analytical Method for Dapagliflozin in Bulk and Pharmaceutical Dosage Form. International Journal of Drug Delivery Technology, 16(24s). https://doi.org/10.25258/ijddt.16.24s.58

Vancouver

Salgar JB, Bais DS, Barkade SS, Mane SR, Doshi RS, Patil MM, et al. Development and Validation of a Stability-Indicating Analytical Method for Dapagliflozin in Bulk and Pharmaceutical Dosage Form. International Journal of Drug Delivery Technology. 2026;16(24s). doi:10.25258/ijddt.16.24s.58

BibTeX
@article{Salgar2026,
  author = {Salgar, Jyoti B. and Bais, Dr. Sanjay and Barkade, Sunil S. and Mane, Sukanya R. and Doshi, Rohit S. and Patil, Manjusha M. and Kamble, Sima T and Mulla, Nida N},
  title = {Development and Validation of a Stability-Indicating Analytical Method for Dapagliflozin in Bulk and Pharmaceutical Dosage Form},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {24s},
  doi = {10.25258/ijddt.16.24s.58}
}
Kostenlos starten →